| Identification | Back Directory | [Name]
Elismetrep | [CAS]
1400699-64-0 | [Synonyms]
Elismetrep
Benzoic acid, 4-[[(4-cyclopropyl-3-isoquinolinyl)[[4-(trifluoromethoxy)phenyl]methyl]amino]sulfonyl]- | [Molecular Formula]
C27H21F3N2O5S | [MOL File]
1400699-64-0.mol | [Molecular Weight]
542.53 |
| Hazard Information | Back Directory | [Uses]
Elismetrep (MT-8554) is an oral active TRPM8 inhibitor, and can be used for study of analgesic[1][2]. | [References]
[1] Conklin M, et al. Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause. Ther Adv Reprod Health. 2023 Jun 22;17:26334941231177611. DOI:10.1177/26334941231177611
[2] Weyer AD, et al. Development of TRPM8 Antagonists to Treat Chronic Pain and Migraine. Pharmaceuticals (Basel). 2017 Mar 30;10(2):37. DOI:10.3390/ph10020037 |
|
|